Who invested in MabVax Therapeutics?
MabVax Therapeutics's investors include National Institutes of Health, Burrill & Company and Numoda Capital Innovations.
United States · Funded startup
6 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$34Mraised across 6 rounds since 2009, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $12M sold, first sale Mar 2015
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Jul 2014
No investor was named in the report.
From a historical funding recordSEC filing: $12M sold, first sale Feb 2014
No investor was named in the report.
From a historical funding recordSEC filing: $500K sold, first sale Aug 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
MabVax Therapeutics's investors include National Institutes of Health, Burrill & Company and Numoda Capital Innovations.
MabVax Therapeutics has raised $34M across 6 rounds since 2009.
MabVax Therapeutics's most recent round was an Undisclosed round of $12M in Apr 2015.
MabVax Therapeutics's largest round on record is $12M (Venture), in Feb 2014.
MabVax Therapeutics's first round on record, in Nov 2012, was backed by Burrill & Company and Numoda Capital Innovations.
MabVax Therapeutics's latest named round is an Undisclosed round, in Apr 2015.
MabVax Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.